Clinical Trial Update: A Study to Evaluate Addition of Peginterferon Alfa-2a to Chronic Hepatitis B (CHB) Patients Treated With NAs [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial aims to evaluate adding peginterferon alfa-2a to chronic hepatitis B patients who are treated with nucleos(t)ide analogs.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Peginterferon alfa-2a (peginterferon alfa-2a)

Snippet

Sponsor: Henan Provincial People's Hospital | Conditions: Chronic Hepatitis B | Phase 4 | Status: UNKNOWN